Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes

Objective. Although the association between chronic kidney disease (CKD) and osteoporotic fractures is well established, data on CKD combined with hip fracture (HF) are scarce and controversial. We aimed to assess in patients with HF the prevalence of CKD, its impact on hospital mortality and length...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander Fisher, Jo-Wai Douglas Wang, Paul N. Smith
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:International Journal of Clinical Practice
Online Access:http://dx.doi.org/10.1155/2024/4456803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698800746102784
author Alexander Fisher
Jo-Wai Douglas Wang
Paul N. Smith
author_facet Alexander Fisher
Jo-Wai Douglas Wang
Paul N. Smith
author_sort Alexander Fisher
collection DOAJ
description Objective. Although the association between chronic kidney disease (CKD) and osteoporotic fractures is well established, data on CKD combined with hip fracture (HF) are scarce and controversial. We aimed to assess in patients with HF the prevalence of CKD, its impact on hospital mortality and length of stay (LOS) and to determine the prognostic value of CKD to predict hospital outcomes. Methods. Prospectively collected clinical data were analysed in 3623 consecutive HF patients aged ≥65 years (mean age 83.4 ± 7.50 [standard deviation] years; 74.4% females). Results. CKD among older patients with HF is highly prevalent (39.9%), has different clinical characteristics, a 2.5-fold higher mortality rate, and 40% greater risk of prolonged LOS. The strongest risk for a poor outcome was advanced age (>80 years). The risk of death substantially increases in combination with chronic disorders, especially coronary artery disease, anaemia, hyperparathyroidism, and atrial fibrillation; models based only on three variables—CKD stage, age >80, and presence of a specific chronic condition—predicted in-hospital death with good discrimination capability (AUC ≥ 0.700) and reasonable accuracy, the number needed to predict ranged between 5.7 and 14.5. Only 12% of HF patients received osteoporotic drugs prefracture. Conclusion. In HF patients with CKD, the risk of adverse outcomes largely increases in parallel with worsening kidney function and, especially, in combination with comorbidities; models based on three admission variables predict a fatal outcome. Assessment of renal function is essential to preventing osteoporotic fractures.
format Article
id doaj-art-a897f9cfeac14547be976bdad2532d6a
institution DOAJ
issn 1742-1241
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series International Journal of Clinical Practice
spelling doaj-art-a897f9cfeac14547be976bdad2532d6a2025-08-20T03:18:48ZengWileyInternational Journal of Clinical Practice1742-12412024-01-01202410.1155/2024/4456803Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and OutcomesAlexander Fisher0Jo-Wai Douglas Wang1Paul N. Smith2Department of Geriatric MedicineDepartment of Geriatric MedicineDepartment of Orthopaedic SurgeryObjective. Although the association between chronic kidney disease (CKD) and osteoporotic fractures is well established, data on CKD combined with hip fracture (HF) are scarce and controversial. We aimed to assess in patients with HF the prevalence of CKD, its impact on hospital mortality and length of stay (LOS) and to determine the prognostic value of CKD to predict hospital outcomes. Methods. Prospectively collected clinical data were analysed in 3623 consecutive HF patients aged ≥65 years (mean age 83.4 ± 7.50 [standard deviation] years; 74.4% females). Results. CKD among older patients with HF is highly prevalent (39.9%), has different clinical characteristics, a 2.5-fold higher mortality rate, and 40% greater risk of prolonged LOS. The strongest risk for a poor outcome was advanced age (>80 years). The risk of death substantially increases in combination with chronic disorders, especially coronary artery disease, anaemia, hyperparathyroidism, and atrial fibrillation; models based only on three variables—CKD stage, age >80, and presence of a specific chronic condition—predicted in-hospital death with good discrimination capability (AUC ≥ 0.700) and reasonable accuracy, the number needed to predict ranged between 5.7 and 14.5. Only 12% of HF patients received osteoporotic drugs prefracture. Conclusion. In HF patients with CKD, the risk of adverse outcomes largely increases in parallel with worsening kidney function and, especially, in combination with comorbidities; models based on three admission variables predict a fatal outcome. Assessment of renal function is essential to preventing osteoporotic fractures.http://dx.doi.org/10.1155/2024/4456803
spellingShingle Alexander Fisher
Jo-Wai Douglas Wang
Paul N. Smith
Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes
International Journal of Clinical Practice
title Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes
title_full Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes
title_fullStr Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes
title_full_unstemmed Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes
title_short Chronic Kidney Disease in Patients with Hip Fracture: Prevalence and Outcomes
title_sort chronic kidney disease in patients with hip fracture prevalence and outcomes
url http://dx.doi.org/10.1155/2024/4456803
work_keys_str_mv AT alexanderfisher chronickidneydiseaseinpatientswithhipfractureprevalenceandoutcomes
AT jowaidouglaswang chronickidneydiseaseinpatientswithhipfractureprevalenceandoutcomes
AT paulnsmith chronickidneydiseaseinpatientswithhipfractureprevalenceandoutcomes